Guan Lincolt Bioengineering Co., Ltd.

Guan Lincolt Bioengineering Co., Ltd.

Gifts & Decorations supplier in China

About Guan Lincolt Bioengineering Co., Ltd.

Linkote Biotech was established in 2004 and specializes in the design, research and development, manufacturing, production and sales of in vitro diagnostic reagents and instruments. Headquartered in Beijing, the largest production base is located in Hebei, with R&D and sales branches in Hong Kong, Singapore and the United States. Since then, Lincote Biotech has become a large-scale technology multinational enterprise with more than 600 employees worldwide. In recent years, the company's business scope has expanded to the research and development, manufacturing and application of high-tech materials, such as the new NOVAtest eco series, the third-party testing and R&D center for medical devices Beta-Bear Lab, etc. Linkote Biotech owns a number of internationally renowned trademarks, including NOVA test, Senso test, Atlas-Link, Beta-Bear, etc. In addition, it owns dozens of patents and inventions. Gu'an Linkote Bioengineering Co., Ltd. was established in 2010 and is located in Langfang City, Hebei Province. It is the largest R&D and production base for in vitro diagnostic reagent products under Linkote Biotech. The base covers a total area of ​​23,000 square meters, with multiple 100,000-grade clean production workshops and inspection areas built in, with a total clean area of ​​1,200 square meters. The production base is now fully semi-automated and partially fully automated, with a monthly production capacity of 15-40 million servings per month. The company's products involve multiple IVD testing platforms, covering ultra-high performance in the fields of fertility assessment testing, infectious diseases, vector-borne diseases, sexually transmitted diseases, markers, indicator substances, addictive substances, etc.

Main products

  • Diagnostic test strips
  • pregnancy test strips
Location:
China
Profile updated March 24, 2026

Similar companies

See all